Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Profit After Tax (2016 - 2025)

Jaguar Health (JAGX) has disclosed Profit After Tax for 11 consecutive years, with -$7.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Profit After Tax rose 27.71% to -$7.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$38.6 million, a 0.8% decrease, with the full-year FY2024 number at -$39.3 million, up 6.32% from a year prior.
  • Profit After Tax was -$7.2 million for Q3 2025 at Jaguar Health, up from -$10.6 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$7.2 million in Q3 2025 to a low of -$18.2 million in Q1 2022.
  • A 5-year average of -$11.1 million and a median of -$10.6 million in 2025 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: tumbled 63.28% in 2021, then surged 42.51% in 2022.
  • Jaguar Health's Profit After Tax stood at -$14.3 million in 2021, then soared by 42.51% to -$8.2 million in 2022, then fell by 13.08% to -$9.3 million in 2023, then fell by 9.94% to -$10.2 million in 2024, then rose by 29.22% to -$7.2 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Profit After Tax are -$7.2 million (Q3 2025), -$10.6 million (Q2 2025), and -$10.6 million (Q1 2025).